期刊文献+

肝移植患者术后感染革兰阴性杆菌的分布及其耐药性分析 被引量:5

Distribution and drug resistance of infection Gram-negative in patients of post-op of liver transplantation
暂未订购
导出
摘要 目的了解肝移植患者术后感染革兰阴性杆菌(G-杆菌)的分布及其耐药性,供临床治疗借鉴。方法采用回顾性分析2003年9月至2005年11月间,从我院肝移植中心103例肝移植术后患者送检的标本中分离到的467株G-杆菌的分布及其耐药情况。结果G-杆菌中,肠杆菌科占77.9%(364/467),最多前3种是大肠埃希菌、阴沟肠杆菌、肺炎克雷伯菌,非发酵菌占22.1%(103/467),最多前3种是嗜麦芽假单胞菌、铜绿假单胞菌、恶臭假单胞菌,检出产ESBLs菌148株,检出率为31.7%(148/467),产ESBLs最严重的细菌分别是铜绿假单胞菌(45.7%)、阴沟肠杆菌(41.8%)、嗜麦芽假单胞菌(40.54%)、肺炎克雷伯菌(34.9%)、大肠埃希菌(32.3%),肠杆菌科耐药率最高依次为哌拉西林、氨苄西林、替卡西林、氨曲南,在89.66%-94.13%,耐药率较低依次是亚胺培南、环丙沙星、阿米卡星、头孢他啶,在5.45%-43.1%,非发酵菌耐药率最高是四环素、氨曲南、哌拉西林、头孢曲松,在59.84%-90.31%,耐药特率最低是阿米卡星、亚胺培南、妥布霉素、替卡西林/克拉维酸,在15.51%-27.63%。结论肝移植患者术后感染的G-杆菌产ESBLs菌高,耐药性严重,应引起关注。 Objective To find out the distribution and the resistance of gram-negative bacilli ( G^- bacilh) in the infected patient after liver transplantation, so as to be used for reference in clinic. Methods From September 2003 to November 2005, the distribution and the resistance of 467 G^-bacilli strains ,which were detected in the samples from 103 patients underwent liver transplantation in the liver transplantation center,were retrospectively analysed. Results Of the G^- bacilli,Enterobacteriaceae was up to 77.9% (364/467) ,and Escherichia coli,E, cloacae,P, maltophilia ,P. putida were the first three respectively, 148 strains which produce ESBLs were found, and it accounts for was 31.7% ( 148/467 ). The most bacteria which produce ESBLs was P. aeruginosa (45.7%) ,E. c/acae(41.8% ) ,P. maltophilia (40.54%) ,P. maltophilia (34.9%) ,Escherichia call (32.3%) respectively. Resistance probability in the Enterobacteriaeea from high to low was piperaeillin, ampicillin, tieareillin, aztreonam, between 89.66 % - 94.31%. Low resistance probability in the Enterobacteriacea was imipenem, cip rofloxacin, amidacin, ceftazidine respectively, between 5.45% - 43.1%. Resistance probability in the Nonfermenters from high to low is tetracycline, aztreonam, piperaeillin, ceftriaxone, between 59.84% - 91.31%. Low resistance probability in the Nonfermenters was amikacin, imipenem, tobramycin, tieareillin/clavulanic, between 15.51% - 27.63%. Conclusions G^-bacilli in the infected patients after liver transplantation most produce EBSLs, and the resistance is serious. All should be pay attention.
出处 《中国微生态学杂志》 CAS CSCD 2007年第1期63-64,共2页 Chinese Journal of Microecology
关键词 肝移植 细菌感染 耐药性 Liver transplantation Bacterial infection Resistance
  • 相关文献

参考文献7

二级参考文献16

  • 1[1]Singh N.Infectious diseases in the liver transplant recipient. Semin Gastrointest Dis,1998; 9(3):136
  • 2[2]George DL,Arnow PM,Fox AS.Bacterial infection as a complication of liver transplantation epidemiology and risk factors.Rev Infect Dis,1991,13(3):387
  • 3[3]Singh N, Paterson DL, Chang FY, et al. Methicillin-resistant Staphylococcus aureus: the other emerging resistant gram-positive coccus among liver transplant recipients. Clin Infect Dis,2000, 30(2):322
  • 4NCCLS Performance Standards for Antimicrobial Susceptibility Testing, Eleventh information supplement. M-100-S11 Vol, 20 Nol 2001,1.
  • 5戴自英,实用抗菌药物学,1992年,160页
  • 6NCCLS. Performance standards for antimicrobial disk susceptibility tests. Approved standard[M]. Eighth Edition. 2003. 20-25.
  • 7岑永康.药物诱发感染[J].药物流行病学杂志,1997,6(1):26-28. 被引量:10
  • 8齐晓涟,王育琴,张京利,王力红.抗菌药物继发真菌感染45例临床分析[J].中国药学杂志,1999,34(4):273-274. 被引量:28
  • 9文天夫,严律南,邓承祺,吴言涛,李波,卢实春,陈晓理,曾勇,赵纪春,汪静,姚辉华.重度肝硬变患者行同种原位肝移植术时凝血功能障碍的诊断与治疗[J].中国普外基础与临床杂志,2000,7(4):235-237. 被引量:25
  • 10严律南.肝硬变门脉高压症的肝脏移植经验[J].中国普外基础与临床杂志,2001,8(4):263-264. 被引量:14

共引文献109

同被引文献62

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部